Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Statement re. Suspension

26 Jun 2012 10:00

RNS Number : 1376G
Adventis Group PLC
26 June 2012
 



26th June 2012

 

ADVENTIS Group Plc (ATG.L)

(the "Group" or the "Company")

 

Suspension of Trading in Ordinary Shares

 

 

Further to the announcements made on 10th May 2012 and 13th June 2012, the Board of Adventis Group Plc announces the suspension of trading in its ordinary shares on AIM as it has now become clear that the Company will not be in a position to publish its audited accounts for the year ended 31 December 2011 ("Annual Accounts") by 30th June 2012 as required under AIM Rule 19. The suspension, which commenced at 10.00 a.m. today, will remain in place until the Group's Annual Accounts have been announced and posted to shareholders.

 

A further announcement will be made in due course.

 

 

Enquiries:

 

Adventis Group Plc Tel: 01494 731600

Nick Winks, Chairman

Andy Pearson, Finance Director

 

Westhouse Securities Limited Tel: 020 7601 6100

Tom Griffiths

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SRSBKADQOBKKNAB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.